(2026). Continuation of beta-blockers during prolonged dobutamine infusion in heart transplant–prioritised patients: A competing-risk analysis. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Continuation of Beta-blockers During Prolonged Dobutamine Infusion in Heart Transplant–prioritised Patients: A Competing-risk Analysis."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Continuation of Beta-blockers During Prolonged Dobutamine Infusion in Heart Transplant–prioritised Patients: A Competing-risk Analysis."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.